Cargando…
Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
Genetic, epidemiologic, and biochemical evidence suggests that predisposition to Alzheimer’s disease (AD) may arise from altered cholesterol metabolism, although the molecular pathways that may link cholesterol to AD phenotypes are only partially understood. Here, we perform a phenotypic screen for...
Autores principales: | van der Kant, Rik, Langness, Vanessa F., Herrera, Cheryl M., Williams, Daniel A., Fong, Lauren K., Leestemaker, Yves, Steenvoorden, Evelyne, Rynearson, Kevin D., Brouwers, Jos F., Helms, J. Bernd, Ovaa, Huib, Giera, Martin, Wagner, Steven L., Bang, Anne G., Goldstein, Lawrence S.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414424/ https://www.ncbi.nlm.nih.gov/pubmed/30686764 http://dx.doi.org/10.1016/j.stem.2018.12.013 |
Ejemplares similares
-
Highlighting the Proteasome: Using Fluorescence to Visualize Proteasome Activity and Distribution
por: Gan, Jin, et al.
Publicado: (2019) -
Using Human iPSC-Derived Neurons to Model TAU Aggregation
por: Verheyen, An, et al.
Publicado: (2015) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014) -
Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018) -
iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)